These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 31987658

  • 1. Clinical Evaluation of Inflammatory and Blood Parameters in the Workup of Pediatric Chronic Abdominal Pain.
    Zeevenhooven J, Rexwinkel R, Tromp E, Haver B, Groeneweg M, Benninga MA, Vlieger AM.
    J Pediatr; 2020 Apr; 219():76-82.e3. PubMed ID: 31987658
    [Abstract] [Full Text] [Related]

  • 2. Fecal Calprotectin as a Useful Non-Invasive Screening Marker for Eosinophilic Gastrointestinal Disorder in Korean Children.
    Yoo IH, Cho JM, Joo JY, Yang HR.
    J Korean Med Sci; 2020 May 04; 35(17):e120. PubMed ID: 32356420
    [Abstract] [Full Text] [Related]

  • 3. Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study.
    Manz M, Burri E, Rothen C, Tchanguizi N, Niederberger C, Rossi L, Beglinger C, Lehmann FS.
    BMC Gastroenterol; 2012 Jan 10; 12():5. PubMed ID: 22233279
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology.
    Dolwani S, Metzner M, Wassell JJ, Yong A, Hawthorne AB.
    Aliment Pharmacol Ther; 2004 Sep 15; 20(6):615-21. PubMed ID: 15352909
    [Abstract] [Full Text] [Related]

  • 5. Noninvasive testing in the management of children with suspected inflammatory bowel disease.
    Dilillo D, Zuccotti GV, Galli E, Meneghin F, Dell'Era A, Penagini F, Colella G, Lewindon P, Carmagnola S, Farina E, Ardizzone S, Maconi G.
    Scand J Gastroenterol; 2019 May 15; 54(5):586-591. PubMed ID: 31032665
    [Abstract] [Full Text] [Related]

  • 6. The combination of fecal calprotectin with ESR, CRP and albumin discriminates more accurately children with Crohn's disease.
    Daniluk U, Daniluk J, Krasnodebska M, Lotowska JM, Sobaniec-Lotowska ME, Lebensztejn DM.
    Adv Med Sci; 2019 Mar 15; 64(1):9-14. PubMed ID: 30237086
    [Abstract] [Full Text] [Related]

  • 7. [Fecal calprotectin as a biomarker to distinguish between organic and functional gastrointestinal disease].
    Bonnín Tomàs A, Vila Vidal M, Rosell Camps A.
    Rev Esp Enferm Dig; 2007 Dec 15; 99(12):689-93. PubMed ID: 18290691
    [Abstract] [Full Text] [Related]

  • 8. Faecal calprotectin effectively excludes inflammatory bowel disease in 789 symptomatic young adults with/without alarm symptoms: a prospective UK primary care cohort study.
    Walker GJ, Moore L, Heerasing N, Hendy P, Perry MH, McDonald TJ, Debenham T, Bethune R, Bewshea C, Hyde C, Heap GA, Singh A, Calvert C, Kennedy NA, Goodhand JR, Ahmad T.
    Aliment Pharmacol Ther; 2018 Apr 15; 47(8):1103-1116. PubMed ID: 29508423
    [Abstract] [Full Text] [Related]

  • 9. Clinical significance of fecal calprotectin for the early diagnosis of abdominal type of Henoch-Schonlein purpura in children.
    Teng X, Gao C, Sun M, Wu J.
    Clin Rheumatol; 2018 Jun 15; 37(6):1667-1673. PubMed ID: 29018973
    [Abstract] [Full Text] [Related]

  • 10. Utility of Fecal Calprotectin in Evaluation of Chronic Gastrointestinal Symptoms in Primary Care.
    Ramraj R, Garcia A, Mosen D, Waiwaiole L, Smith N.
    Clin Pediatr (Phila); 2018 Aug 15; 57(9):1058-1063. PubMed ID: 29192504
    [Abstract] [Full Text] [Related]

  • 11. Faecal calprotectin, an useful marker in discriminating between inflammatory bowel disease and functional gastrointestinal disorders.
    Lozoya Angulo ME, de Las Heras Gómez I, Martinez Villanueva M, Noguera Velasco JA, Avilés Plaza F.
    Gastroenterol Hepatol; 2017 Mar 15; 40(3):125-131. PubMed ID: 27260632
    [Abstract] [Full Text] [Related]

  • 12. Predicting inflammatory bowel disease in children with abdominal pain and diarrhoea: calgranulin-C versus calprotectin stool tests.
    Heida A, Van de Vijver E, van Ravenzwaaij D, Van Biervliet S, Hummel TZ, Yuksel Z, Gonera-de Jong G, Schulenberg R, Muller Kobold A, van Rheenen PF, CACATU consortium.
    Arch Dis Child; 2018 Jun 15; 103(6):565-571. PubMed ID: 29514815
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic Accuracy of Fecal Calprotectin for Pediatric Inflammatory Bowel Disease in Primary Care: A Prospective Cohort Study.
    Holtman GA, Lisman-van Leeuwen Y, Kollen BJ, Norbruis OF, Escher JC, Kindermann A, de Rijke YB, van Rheenen PF, Berger MY.
    Ann Fam Med; 2016 Sep 15; 14(5):437-45. PubMed ID: 27621160
    [Abstract] [Full Text] [Related]

  • 14. Faecal calprotectin concentrations in children with functional gastrointestinal disorders diagnosed according to the Pediatric Rome III criteria.
    Flagstad G, Helgeland H, Markestad T.
    Acta Paediatr; 2010 May 15; 99(5):734-737. PubMed ID: 20219041
    [Abstract] [Full Text] [Related]

  • 15. Associations Among Mucosal and Transmural Healing and Fecal Level of Calprotectin in Children With Crohn's Disease.
    Weinstein-Nakar I, Focht G, Church P, Walters TD, Abitbol G, Anupindi S, Berteloot L, Hulst JM, Ruemmele F, Lemberg DA, Leach ST, Cytter R, Greer ML, Griffiths AM, Turner D, ImageKids study group.
    Clin Gastroenterol Hepatol; 2018 Jul 15; 16(7):1089-1097.e4. PubMed ID: 29501599
    [Abstract] [Full Text] [Related]

  • 16. Fecal calprotectin and C-reactive protein are associated with positive findings in capsule endoscopy in suspected small bowel Crohn's disease.
    Egea Valenzuela J, Pereñíguez López A, Pérez Fernández V, Alberca de Las Parras F, Carballo Álvarez F.
    Rev Esp Enferm Dig; 2016 Jul 15; 108(7):394-400. PubMed ID: 27312194
    [Abstract] [Full Text] [Related]

  • 17. Paediatric Rome III Criteria-Related Abdominal Pain Is Associated With Helicobacter pylori and Not With Calprotectin.
    Sýkora J, Huml M, Siala K, Pomahačová R, Jehlička P, Liška J, Kuntscherová J, Schwarz J.
    J Pediatr Gastroenterol Nutr; 2016 Oct 15; 63(4):417-22. PubMed ID: 26913755
    [Abstract] [Full Text] [Related]

  • 18. Consecutive fecal calprotectin measurements for predicting relapse in pediatric Crohn's disease patients.
    Foster AJ, Smyth M, Lakhani A, Jung B, Brant RF, Jacobson K.
    World J Gastroenterol; 2019 Mar 14; 25(10):1266-1277. PubMed ID: 30886509
    [Abstract] [Full Text] [Related]

  • 19. The use of fecal calprotectin as a biomarker in gastrointestinal disease.
    Burri E, Beglinger C.
    Expert Rev Gastroenterol Hepatol; 2014 Feb 14; 8(2):197-210. PubMed ID: 24345070
    [Abstract] [Full Text] [Related]

  • 20. Fecal calprotectin complements routine laboratory investigations in diagnosing childhood inflammatory bowel disease.
    Quail MA, Russell RK, Van Limbergen JE, Rogers P, Drummond HE, Wilson DC, Gillett PM.
    Inflamm Bowel Dis; 2009 May 14; 15(5):756-9. PubMed ID: 19107785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.